SANTA CLARA, Calif., Nov. 7 -- Applied Imaging Corp. has announced the formation of a clinical research imaging collaboration with the Department of Anatomic Pathology at The Cleveland Clinic Foundation.
The Cleveland Clinic has purchased the company's Ariol automated image analysis system for use in its pathology research programs. Investigators have begun to use the Ariol system in their research programs to more precisely characterize gene and protein expression patterns in a variety of cancers.
Scientists at The Cleveland Clinic will also evaluate new applications under development by Applied Imaging and provide input into the design of novel imaging applications for the detection of extremely low levels of gene amplification that may enhance the utility of other technologies already under development at the clinic.
"Highly precise, quantitative measurement technologies are essential tools to help us advance our understanding of the molecular and protein pathways that are of clinical relevance in a number of cancers," said John Goldblum, MD, chairman of anatomic pathology at clinic. "These second-generation systems developed by Applied Imaging have the capability to substantially accelerate our research efforts in these areas. In addition, we look forward to participating in the development and testing of a number of new microscopic imaging applications with the company's scientists."
For more information, visit: www.aicorp.com